Same-day 90Y radioembolization: implementing a new treatment paradigm

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 43, Issue 13, 2016, Pages 2353-2359

  Gabr, Ahmed ^a   Kallini, Joseph Ralph ^a   Gates, Vanessa L ^a   Hickey, Ryan ^a   Kulik, Laura ^b   Desai, Kush ^a   Thornburg, Bartley ^a   Marshall, Karen ^a   Salzig, Krystina ^a   Williams, Melissa ^a   del Castillo, Carlene ^a   Ganger, Daniel ^b   Hohlastos, Elias ^a   Baker, Talia ^b   Lewandowski, Robert J ^a   Salem, Riad ^a,b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Lung shunting fraction; Radioembolization; Same day

Indexed keywords

MACROSALB TC 99M; YTTRIUM 90; RADIOPHARMACEUTICAL AGENT; YTTRIUM;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BREAST CANCER; CANCER RADIOTHERAPY; CHOLECYSTITIS; COIL EMBOLIZATION; CONE BEAM COMPUTED TOMOGRAPHY; DOSIMETRY; DRUG DOSE ESCALATION; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER PERFUSION; LOW DRUG DOSE; LUNG SHUNTING; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMOR; PAROTID GLAND CANCER; PAROTID SARCOMA; RADIATION DOSE; RADIATION PNEUMONIA; RADIOEMBOLIZATION; RADIOISOTOPE THERAPY; RETROSPECTIVE STUDY; SARCOMA; SCINTIGRAPHY; STOMACH ULCER; TUMOR VOLUME; ARTIFICIAL EMBOLIZATION; DIAGNOSTIC IMAGING; LIVER NEOPLASMS; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84975117329     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-016-3438-x     Document Type: Article

References (18)

1. Ahmadzadehfar H, Meyer C, Ezziddin S, Sabet A, Hoff-Meyer A, Muckle M, et al. Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study. Eur J Nucl Med Mol Imaging. 2013;40:80–90. doi:10.1007/s00259-012-2253-2.
2. Habib A, Desai K, Hickey R, Thornburg B, Lewandowski R, Salem R. Locoregional therapy of hepatocellular carcinoma. Clin Liver Dis. 2015;19:401–20. doi:10.1016/j.cld.2015.01.008.
3. Dezarn WA, Cessna JT, DeWerd LA, Feng W, Gates VL, Halama J, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys. 2011;38:4824–45.
4. Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C, et al. Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study. Hepatology. 2013;57:1826–37. doi:10.1002/hep.26014.
5. Gates VL, Marshall KG, Salzig K, Williams M, Lewandowski RJ, Salem R. Outpatient single-session yttrium-90 glass microsphere radioembolization. J Vasc Interv Radiol. 2014;25:266–70. doi:10.1016/j.jvir.2013.11.005.
6. Hamami ME, Poeppel TD, Muller S, Heusner T, Bockisch A, Hilgard P, et al. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. Eur J Nucl Med. 2009;50:688–92. doi:10.2967/jnumed.108.058347.
7. Louie JD, Kothary N, Kuo WT, Hwang GL, Hofmann LV, Goris ML, et al. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol. 2009;20:606–13. doi:10.1016/j.jvir.2009.01.021.
8. 90Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction? Eur J Nucl Med Mol Imaging. 2015;42:2038–44. doi:10.1007/s00259-015-3122-6.
9. Leung TW, Lau WY, Ho SK, Ward SC, Chow JH, Chan MS, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33:919–24. doi:10.1016/0360-3016(95)00039-3.
10. Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, et al. Biliary sequelae following radioembolization with yttrium-90 microspheres. J Vasc Interv Radiol. 2008;19:691–7. doi:10.1016/j.jvir.2008.01.003.
11. European Association for Study of Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48:599–641. doi:10.1016/j.ejca.2011.12.021.
12. Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12:321–6.
13. Abando A, Hood D, Weaver F, Katz S. The use of the Angioseal device for femoral artery closure. J Vasc Surg. 2004;40:287–90. doi:10.1016/j.jvs.2004.05.007.
14. Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK, et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol. 2013;59:1029–36. doi:10.1016/j.jhep.2013.06.015.
15. 90Y radiation lobectomy: outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes. J Surg Oncol. 2016. doi:10.1002/jso.24269.
16. Vouche M, Habib A, Ward TJ, Kim E, Kulik L, Ganger D, et al. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology. 2014;60:192–201. doi:10.1002/hep.27057.
17. Heusner TA, Hamami ME, Ertle J, Hahn S, Poeppel T, Hilgard P, et al. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Rofo. 2010;182:603–8. doi:10.1055/s-0029-1245192.
18. Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek Jr AA, Kulik L, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30:571–92. doi:10.1007/s00270-007-9064-z.